tiprankstipranks
AbbVie price target raised to $214 from $212 at Guggenheim
PremiumThe FlyAbbVie price target raised to $214 from $212 at Guggenheim
4d ago
AbbVie price target raised to $215 from $205 at Citi
Premium
The Fly
AbbVie price target raised to $215 from $205 at Citi
4d ago
AbbVie Reports Strong 2024 Growth Amid Challenges
Premium
Company Announcements
AbbVie Reports Strong 2024 Growth Amid Challenges
6d ago
AbbVie rises 7.4%
PremiumThe FlyAbbVie rises 7.4%
7d ago
Unusually active option classes on open January 31st
Premium
The Fly
Unusually active option classes on open January 31st
7d ago
AbbVie sees Q1 adjusted EPS $2.47-$2.51, consensus $2.59
Premium
The Fly
AbbVie sees Q1 adjusted EPS $2.47-$2.51, consensus $2.59
7d ago
AbbVie says ‘very pleased’ with progress in 2024, sees ‘strong growth’ in 2025
PremiumThe FlyAbbVie says ‘very pleased’ with progress in 2024, sees ‘strong growth’ in 2025
7d ago
Morning Movers: Apple and Exxon higher following quarterly earnings
Premium
The Fly
Morning Movers: Apple and Exxon higher following quarterly earnings
7d ago
AbbVie reports Q4 adjusted EPS $2.16, consensus $2.26
Premium
The Fly
AbbVie reports Q4 adjusted EPS $2.16, consensus $2.26
7d ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100